Sirolimus (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sirolimus" in Polish language version.

refsWebsite

Global rank Polish rank

4^th place

7^th place

2^nd place

6^th place

4,294^th place

205^th place

1^st place

447^th place

1,118^th place

5^th place

2^nd place

222^nd place

228^th place

doi.org

C.C. Vézina C.C., A.A. Kudelski A.A., S.N.S.N. Sehgal S.N.S.N., Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle, „The Journal of Antibiotics”, 28 (10), 1975, s. 721–726, DOI: 10.7164/antibiotics.28.721, PMID: 1102508 .
S.O.S.O. Marx S.O.S.O. i inni, Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells, „Circulation Research”, 76 (3), 1995, s. 412–417, DOI: 10.1161/01.res.76.3.412, PMID: 7532117 .
M.M. Poon M.M. i inni, Rapamycin inhibits vascular smooth muscle cell migration, „The Journal of Clinical Investigation”, 98 (10), 1996, s. 2277–2283, DOI: 10.1172/JCI119038, PMID: 8941644, PMCID: PMC507677 .
JeanJ. Fajadet JeanJ. i inni, Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial, „Circulation”, 111 (8), 2005, s. 1040–1044, DOI: 10.1161/01.CIR.0000156334.24955.B2, PMID: 15723977 .
Jeffrey W.J.W. Moses Jeffrey W.J.W. i inni, Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, „The New England Journal of Medicine”, 349 (14), 2003, s. 1315–1323, DOI: 10.1056/NEJMoa035071, PMID: 14523139 .

FDA approves Rapamune to treat LAM, a very rare lung disease [online], U.S. Food and Drug Administration, 28 maja 2015 [zarchiwizowane z adresu 2018-01-26] .

C.C. Vézina C.C., A.A. Kudelski A.A., S.N.S.N. Sehgal S.N.S.N., Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle, „The Journal of Antibiotics”, 28 (10), 1975, s. 721–726, DOI: 10.7164/antibiotics.28.721, PMID: 1102508 .
S.O.S.O. Marx S.O.S.O. i inni, Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells, „Circulation Research”, 76 (3), 1995, s. 412–417, DOI: 10.1161/01.res.76.3.412, PMID: 7532117 .
M.M. Poon M.M. i inni, Rapamycin inhibits vascular smooth muscle cell migration, „The Journal of Clinical Investigation”, 98 (10), 1996, s. 2277–2283, DOI: 10.1172/JCI119038, PMID: 8941644, PMCID: PMC507677 .
JeanJ. Fajadet JeanJ. i inni, Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial, „Circulation”, 111 (8), 2005, s. 1040–1044, DOI: 10.1161/01.CIR.0000156334.24955.B2, PMID: 15723977 .
Jeffrey W.J.W. Moses Jeffrey W.J.W. i inni, Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, „The New England Journal of Medicine”, 349 (14), 2003, s. 1315–1323, DOI: 10.1056/NEJMoa035071, PMID: 14523139 .

FDA approves Rapamune to treat LAM, a very rare lung disease [online], U.S. Food and Drug Administration, 28 maja 2015 [zarchiwizowane z adresu 2018-01-26] .

Adam Wawrzyński. Żyć długo i szczęśliwie. „Świat Nauki”. nr. 8 (240), s. 18, sierpień 2011. Prószyński Media. ISSN 0867-6380.